Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization
Article in Discover Oncology (April 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis
Article in Journal of Pharmaceutical Analysis (April 2024)
YAP1-induced RBM24 promotes the tumorigenesis of triple-negative breast cancer through the β-catenin pathway.
Article in Journal of Investigative Medicine (March 2024)